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Table  1  Potential  beneﬁts  of  revascularization  of  coronary
chronic  total  occlusions3
Improved  symptoms
Decreased  need  for  myocardial  revascularization  surgery
Decreased  need  for  antianginal  medications
Reduced  mortality
Optimization  of  left  ventricular  function
Improved  tolerance  of  acute  coronary  syndromes  that  might
occur in  the  future
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iThe  treatment  of  a  coronary  chronic  total  occlusion  is  one  of
the  main  challenges  of  interventionist  cardiology.  Based  on
angiographs,  the  prevalence  is  15  to  20%.  Revascularization
is  indicated  less  frequently  due  to  a  greater  failure  rate,
greater  exposure  to  radiation,  high  cost,  and  a  greater  fre-
quency  of  complications.  Therefore,  only  35%  of  coronary
chronic  total  occlusions  are  reportedly  referred  for  revascu-
larization,  in  which  cases  success  is  close  to  80%.
Uncertainties  remain  regarding  the  beneﬁts  of  treat-
ment,  according  to  information  obtained  from  observational
studies1.  Patients  are  referred  due  to  their  symptoms,  or
because  of  signiﬁcant  ischemia  on  non-invasive  tests.  The
proportion  of  asymptomatic  individuals  is  close  to  10%.  Find-
ing  a  chronic  total  occlusion  is  one  of  the  main  reasons  for
referring  a  patient  to  coronary  surgery.
Fundamentals
The  indication  for  revascularization  of  a  coronary  chronic
total  occlusion  is  based  on  the  severity  of  the  symptoms,  theDOI of original article:
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he  operator’s  experience  versus  the  angiographic  complex-
ty  of  the  occlusion  (objectiﬁable  using  clinical-angiographic
cores  such  as  the  J-CTO  score),  should  be  analyzed3. Treat-
ent  is  begun  with  optimal  medical  management  and  risk
tratiﬁcation.  The  greater  the  risk  (e.g.  a  greater  area  of
schemia),  the  greater  the  beneﬁt  of  angioplasty,  and  the
ore  appropriate  its  indication.
Table  1  shows  the  beneﬁts  of  percutaneous  intervention.
In  Joyal’s  meta-analysis4 of  13  observational  studies,ortality  at  six  years  was  lower  in  the  group  with
ascular. Published by Elsevier Espan˜a, S.L.U. This is an open access
nses/by-nc-nd/4.0/).
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tigure  1  Kaplan-Meier  curves  for  cardiovascular  mortality  (A
reatment in  the  presence  of  collateral  circulation.
successful  rechanneling  of  the  coronary  chronic  total
cclusion,  compared  with  the  group  that  was  not  rechan-
eled  (14.3%  vs.  17.5%;  OR  0,56).
pproach to the patient with coronary chronic
otal occlusion
hen  coronary  chronic  total  occlusion  is  found,  the  follow-
ng  factors  are  considered  relevant.
resence  and  degree  of  ischemia
evascularization  will  be  appropriate  in  patients  with  signif-
cant  ischemia,  even  if  they  are  asymptomatic,  and/or  have
egional  dysfunction  of  the  left  ventricle.  Most  cases  of  coro-
ary  chronic  total  occlusion  will  have  signiﬁcant  ischemia,
nd  it  has  been  shown  that  angioplasty  of  a  coronary  chronic
otal  occlusion  signiﬁcantly  reduces  ischemia,  with  a  cut-off
oint  of  12.5%  ischemic  burden  as  a  predictor  of  beneﬁt,
nd,  lacking  this,  in  ischemias  lower  than  6.25%5.
Typically,  patients  with  coronary  chronic  total  occlusion
ave  collaterals  to  the  distal  segment,  but  these  do  not
rovide  sufﬁcient  ﬂow  to  the  myocardium.  Sachdeva  et  al.,
sing  FFR,  showed  that  each  coronary  chronic  total  occlu-
ion  was  hemodynamically  signiﬁcant,  even  with  important
ollaterals6.  A  recent  study  comparing  medical  management
f  coronary  chronic  total  occlusion  with  collaterals  (Rentrop
II)  vs.  percutaneous  treatment,  showed  a  lower  incidence
f  cardiac  death7 (HR:0.29;  p  <  0.01)  and  MACE  (HR:0.32)  in
he  revascularization  group  (Fig.  1).
resence  of  symptoms
uccessful  revascularization  of  a  coronary  chronic  total
cclusion  is  associated  with  an  improvement  in  symptoms.
eneﬁts  include  decreased  limitation  of  physical  activity,
ewer  episodes  of  angina,  and  a  better  quality  of  life. meta-analysis  showed  that  successful  rechanneling  of  a
oronary  chronic  total  occlusion  produced  greater  symp-
om  relief  in  long-term  follow  up,  compared  with  the
roup  where  vessel  rechanneling  was  unsuccessful4. In  the
p
s
b
n MACE  (B)  in  patients  undergoing  revascularization  vs.  medical
ACTOR  study,  Grantham  reported  signiﬁcant  improvement
t  one  month  using  the  Seattle  Angina  Questionnaire  in
reated  symptomatic  patients8.
ossibility  of  success
he  success  rate  in  coronary  chronic  total  occlusion  ranged
rom  50%  to  75%.  Advances  in  techniques,  new  dedicated
uide  wires,  microcatheters  and  greater  operator  expe-
ience  have  increased  the  success  rate.  The  Euro  CTO
lub  reports  83%  success,  and  in  Japan  and  groups  in
he  USA  with  hybrid  confrontation,  rates  close  to  90%  are
eported.  Against  these  ﬁgures,  however,  there  is  a  greater
ate  of  complications,  especially  coronary  perforation
3%),  periprocedural  infarction  (2.4%)  and  contrast-induced
ephropathy  (3%).  Mortality  is  between  0.2  and  1.3%.  The
perator’s  learning  curve  and  experience  is  a  factor  that
hould  be  considered.
oronary chronic total occlusion in the
resence of multivessel disease
oronary  chronic  total  occlusion  is  common  in  multives-
el  disease  and  determines  the  option  of  revascularization.
n  the  Canadian  Registry  of  coronary  chronic  occlusions9,
ultivessel  disease  was  present  in  ¾ of  patients,  a  ﬁnding
ssociated  with  greater  referral  for  surgery.
Furthermore,  if  percutaneous  treatment  is  selected  in
his  context  and  there  is  a  chronic  total  occlusion,  failed
evascularization  is  frequent.  There  is  current  evidence  to
how  that  incomplete  revascularization  in  multivessel  dis-
ase  treatment  is  a  determining  factor  in  a  worse  prognosis.
iability  and  ventricular  dysfunction
atients  with  multivessel  disease  frequently  present  a  his-
ory  of  infarction  and  left  ventricular  dysfunction  with
otentially  recoverable  territory.  The  diagnostic  tools  for
eeking  viability  are  crucial  for  evaluating  the  potential
eneﬁt  of  revascularization.  In  our  experience,  nuclear  mag-
etic  resonance  is  the  method  of  choice  since  in  its  delayed
ions:
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1Percutaneous  coronary  intervention  in  coronary  total  occlus
contrast  analysis  the  extent  of  necrosis  in  the  myocardial
wall  thickness  can  be  determined.  Necrosis  of  less  than  75%
of  the  thickness  could  be  beneﬁted  by  a  percutaneous  revas-
cularization,  with  the  beneﬁcial  effect  increasing  as  the
percentage  of  necrosis  decreases.  A  meta-analysis  published
in  2015  by  Hoebers10 showed  that  following  percutaneous
rechanneling  of  a  coronary  chronic  total  increased  4.4%  (95%
CI;  3.52-5.35,  p  <  0.01)  compared  to  baseline.  In  addition,  a
decrease  in  end  diastolic  volume  was  reported.
Revascularization  of  a  coronary  chronic  total
occlusion in post  acute  myocardial  infarction
patients
Among  acute  myocardial  infarction  patients,  approximately
40  to  60%  have  multivessel  disease,  and  it  is  estimated  that
close  to  10%  have  a  coronary  chronic  total  occlusion  in  a
vessel  unrelated  to  the  infarction.  Multivessel  disease  with
a  coronary  chronic  total  occlusion  is  an  independent  pre-
dictor  of  mortality  during  infarction.  The  COREA-AMI  study
notes  that  patients  who  underwent  a  successful  percuta-
neous  rechanneling  of  the  coronary  chronic  total  occlusion
(not  responsible  for  the  infarct)  had  a  lower  global  mortal-
ity  (16.7  vs.  32.3%)  and  MACE  (21.9  vs.55.2%)  compared  with
the  non-treated  group11,  which  suggests  the  relevance  of  the
treatment  in  this  context.
Conclusions
Percutaneous  interventionism  of  the  coronary  chronic  total
occlusion  may  provide  signiﬁcant  beneﬁts  for  the  patient
when  it  is  clinically  indicated  and  the  procedure  is  appro-
priate.  Patients  should  be  treated  according  to  their
symptoms  or  evidence  of  ischemia,  in  viable  territory,  and
not  according  to  the  operator’s  skills  (risk  of  inappropri-
ate  angioplasty).  The  myocardium  irrigated  by  a  coronary
chronic  total  occlusion  will  always  be  an  ischemic  zone,  even
in  the  presence  of  good  collateral  circulation.  Extensive
ischemia,  coronary  chronic  total  occlusion  in  the  presence
of  multivessel  disease,  or  acute  myocardial  infarction,  is
associated  with  a  worse  prognosis.  Successful  treatment
is  associated  with  fewer  symptoms,  better  quality  of  life
and  optimization  of  ventricular  function  indices.  Beneﬁts
have  been  reported  with  regard  to  cardiovascular  mortality,
although  there  are  no  deﬁnitive  data,  as  yet12.  Success-
ful  complete  percutaneous  revascularization  should  be  the
goal,  a  factor  which  should  increase  the  number  of  treated
coronary  chronic  total  occlusion  patients.  The  foregoing  sup-
ports  the  idea  of  developing  coronary  chronic  total  occlusion
programs  with  dedicated  operators  having  more  than  50
1 In  which  patients?  e5
oronary  chronic  total  occlusion  procedures/year,  as  well
s  referral  networks,  in  order  to  optimize  patient  selection,
aximize  success,  and  decrease  possible  complications.
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